Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 643834
MIM: 169710
HGNC: 8885
Ensembl: ENSG00000229859
Variants:
dbSNP: 643834
ClinVar: 643834
TCGA: ENSG00000229859
COSMIC: PGA3
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000229859 | ENST00000325558 | P0DJD8 |
| ENSG00000229859 | ENST00000538258 | F5H0H6 |
| ENSG00000229859 | ENST00000543125 | F5GXL4 |
| ENSG00000229859 | ENST00000543505 | F5H842 |
Expression (GTEx)
Pathways
| Pathway | Source | External ID |
|---|---|---|
| Protein digestion and absorption | KEGG | ko04974 |
| Protein digestion and absorption | KEGG | hsa04974 |
| Metabolism of proteins | REACTOME | R-HSA-392499 |
| Surfactant metabolism | REACTOME | R-HSA-5683826 |
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 34817333 | 2021 | Diagnostic value of MRI-DWI signal intensity value combined with serum PGI, PGII and CA199 in early gastric cancer. | 2 |
| 34817333 | 2021 | Diagnostic value of MRI-DWI signal intensity value combined with serum PGI, PGII and CA199 in early gastric cancer. | 2 |
| 31414587 | 2019 | Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study. | 7 |
| 31414587 | 2019 | Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study. | 7 |
| 24895149 | 2015 | Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. | 23 |
| 24895149 | 2015 | Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. | 23 |
| 25292040 | 2014 | Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti- CagA antibodies in dyspeptic patients over 50 years old in Guilan Province, north of Iran. | 3 |
| 25292040 | 2014 | Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti- CagA antibodies in dyspeptic patients over 50 years old in Guilan Province, north of Iran. | 3 |
| 23886209 | 2013 | Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions. | 11 |
| 23886209 | 2013 | Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions. | 11 |
| 21175799 | 2011 | Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study. | 10 |
| 21175799 | 2011 | Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study. | 10 |
| 18844222 | 2009 | Serum pepsinogens and risk of esophageal squamous dysplasia. | 20 |
| 19196398 | 2009 | Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan. | 6 |
| 18844222 | 2009 | Serum pepsinogens and risk of esophageal squamous dysplasia. | 20 |
Citation
Dessen P
PGA3 (pepsinogen A3)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/43715/pga3
